Related Experiment Videos

Determinants of prothrombinase activity and modification of prothrombin conversion by thrombin-treated factor V

C Kandall, T K Akinbami, R W Colman

British Journal of Haematology

|December 1, 1972

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).

Thrombosis and haemostasis·2011

Platelet cAMP and cGMP Phosphodiesterases.

Platelets·2010

Cleaved high molecular weight kininogen inhibits tube formation of endothelial progenitor cells via suppression of matrix metalloproteinase 2.

Journal of thrombosis and haemostasis : JTH·2009

Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway.

Oncogene·2009

Domain 5 of kininogen inhibits proliferation of human colon cancer cell line (HCT-116) by interfering with G1/S in the cell cycle.

Journal of thrombosis and haemostasis : JTH·2006

Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005

See all related articles